Newsletter | May 31, 2024

05.31.24 -- Realizing The Value Of RWD

SPONSOR

Webinar: How New Technologies are Transforming Pharmacovigilance and Improving Patient Safety

Join speakers from Incyte, Oracle, Optimapharm and PharmaLex to explore how new technologies are making safety processes faster and more accurate - freeing safety and clinical teams while enhancing patient safety. Review business cases of new safety technologies in use today; Assess the promise and challenges of using AI in pharmacovigilance; Obtain critical questions to ask when evaluating new safety technologies. Register Today.

CLINICAL DATA MANAGEMENT & ANALYTICS

Realizing The Value Of RWD

e-book | Clinical Leader

Able to add data richness and accuracy to clinical trial data and results, real-world data (RWD) has the potential to improve clinical trial design, influence regulatory approval, and, overall, positively affect drug development.

Digital Biomarkers: Unveiling 5 Key Benefits In Clinical Trials

Article | Roche Information Solutions

Explore five key advantages that underscore the significance of digital measurement in the context of clinical trials, with a particular focus on Parkinson's disease studies.

Trends Shaping The Pharmaceutical Industry's Future

Article | By Seema Verma, Oracle Life Sciences

Decentralized trials and patient choice are key to expanding study reach. Examine how patient access increases with diverse options and AI-powered connections across health systems and community sites.

TA Scan: Enhancing Strategies With Advanced Analytics And ML

Brochure | Anju Software

Start making data-driven decisions for your clinical trial workflows by utilizing this platform to analyze, measure, and rank trial and site data, including KOL and PI experience and involvement.

Shorten The Path: From Discovery To Approval Of Novel Therapies

Case Study | Medidata AI

Unearth how this trial design solution was able to utilize historical trial data and real-life examples across different indications throughout the clinical development process in five case studies.

TRIAL MONITORING

The FDA Advocates For Quality Management: Why Is It Still Being Ignored?

Guest Column | By Penelope Przekop, MSQA, RQAP-GCP

The FDA's quality by design and risk-based monitoring messaging began more than 10 years ago with their guidance on RBM. Eleven years, five total related key guidance documents, and one global pandemic later, why aren’t we moving forward faster?

Clinical Quality Assurance And Compliance Oversight

Brochure | Advarra

Consider this tailored assessment and support offerings in clinical quality assurance (CQA) compliance, designed to safeguard adherence to relevant regulations and good clinical practice (GCP).

EVENTS

Global Clinical Trial Disclosures and Data Transparency Conference

September 23 - 24, 2024 | Arlington, Virginia
Clinical trial information transparency is taking on new dimensions. Explore the newest standards in clinical trial disclosure and data transparency, exchange best practices, and delve into thorough discussions on trending subjects. Click here to register!

CHOOSE YOUR OWN ADVENTURE

You're receiving the Friday edition of the Clinical Leader newsletter, focusing on Clinical Data Management & Analytics and Trial Monitoring. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: